Constipation affects 6-11%
These drugs have individually demonstrated efficacy in glycemic control, weight loss, blood pressure reduction and reducing the risk of renal and heart failure
On Monday, the Scottish Medicines Consortium (SMC) announced it had now recommended Wegovy semaglutide injection as the first GLP-1 RA to reduce the risk of major adverse cardiovascular events (MACE) - cardiovascular death or non-fatal heart attacks and strokes - for some patients
Remember, however, that this doesn't replace or override the manufacturer's advice
Consistency beats intensity
The biomimetic nanodelivery systems (BNDSs) were developed more recently and exhibit the advantages of inherent natural biocompatibility, low immunogenicity, and promising potential due to the fact that they are made directly from cell membranes (normal or diseased cells) or by coating nanoparticle surface with cell membranes [11]